Ceapro Inc. (OTCMKTS:CRPOF – Get Free Report) shares rose 4.2% on Tuesday . The company traded as high as $0.18 and last traded at $0.18. Approximately 650 shares were traded during trading, a decline of 94% from the average daily volume of 10,393 shares. The stock had previously closed at $0.18.
Ceapro Stock Performance
The stock’s 50 day moving average price is $0.16 and its 200 day moving average price is $0.18. The company has a market capitalization of $14.45 million, a P/E ratio of -9.23 and a beta of 1.53.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Articles
- Five stocks we like better than Ceapro
- What is Short Interest? How to Use It
- Charles Schwab Fortifies its Uptrend on EPS Beat
- 10 Best Airline Stocks to Buy
- Lockheed Martin Stock Aims for a Fresh All-Time High
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.